ATP5F1 (also termed ATP5B) is the beta subunit of the F1 complex in ATP synthase, encoded by the ATP5F1B gene. Antibodies against ATP5F1 are primarily used to:
Detect ATP synthase expression in mitochondrial and cellular studies .
Investigate aberrant ATP5F1 localization in cancer cells, where it may serve as a tumor-associated antigen .
Study metabolic reprogramming in diseases such as neurodegenerative disorders and cancers .
Surface Localization in NSCLC: ATP5F1 was identified on the plasma membrane of non-small cell lung cancer (NSCLC) cells using monoclonal antibody 4E7. Immunohistochemistry revealed ectopic expression in 71.88% of lung adenocarcinomas and 66.67% of squamous carcinomas, compared to 25.81% in adjacent non-tumor tissues .
Functional Impact: Treatment with anti-ATP5F1 antibody (4E7) inhibited A549 lung adenocarcinoma cell proliferation by ~40% at 80 μg/mL after 72 hours (p < 0.05) .
Mitochondrial vs. Cell Surface ATP5F1: While ATP5F1 is typically mitochondrial, its ectopic cell surface expression in NSCLC suggests a role in tumor microenvironment adaptation .
ATP-Binding Antibody Platforms: Studies on ATP-dependent antibodies (e.g., STA551 for CD137) highlight the potential to exploit extracellular ATP in tumors (>100 μM vs. <100 nM in normal tissues) for targeted therapies . Though not directly targeting ATP5F1, these platforms underscore the broader relevance of ATP-metabolizing proteins in oncology .
Cross-Reactivity: Antibodies like ab217054 show high specificity for human ATP5F1 but not murine orthologs .
Phosphorylation Studies: Antibodies targeting phosphorylated ATP synthase subunits (e.g., PKCα-dependent sites) require validation in knockout models to confirm specificity .
Therapeutic Targeting: ATP5F1’s surface expression in NSCLC warrants exploration for antibody-drug conjugates (ADCs) or immune checkpoint modulation .
Metabolic Dysregulation: ATP5F1 antibodies could elucidate mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases, where ATP synthase activity is compromised .
KEGG: ath:ArthCp008
STRING: 3702.ATCG00130.1
AtpF is a critical subunit of ATP synthase complexes found in various organisms, including plants and bacteria. In plants, it functions as the CF0I subunit of chloroplast ATP synthase, playing an essential role in energy production through photosynthesis . In bacterial systems like Escherichia coli, atpF is part of the membrane-bound F0 sector of ATP synthase that facilitates proton translocation across membranes during ATP synthesis . The importance of atpF in bioenergetics research stems from its conservation across species and its central role in ATP production, making it a valuable target for studying energy metabolism in different organisms and experimental models. Understanding atpF structure and function provides insights into fundamental cellular energetics and potential applications in biotechnology and medicine.
Polyclonal atpF antibodies, such as those derived from rabbit sera as described in the product information, recognize multiple epitopes on the atpF protein, providing robust signal detection across various applications including Western blotting, ELISA, and immunohistochemistry . These antibodies offer higher sensitivity and are particularly useful when protein concentrations are low or when the target protein undergoes conformational changes during experimental procedures.
In contrast, monoclonal antibodies (not specifically mentioned in the search results for atpF) recognize single epitopes, offering higher specificity but potentially lower sensitivity. For atpF research, the choice between polyclonal and monoclonal antibodies depends on the experimental goals: polyclonal antibodies excel in initial detection and characterization experiments, while monoclonal antibodies would be preferable for discriminating between closely related ATP synthase subunits or for standardized assays requiring consistent lot-to-lot performance.
Species cross-reactivity is a critical consideration when selecting atpF antibodies. As seen in the search results, antibodies against plant atpF from Arabidopsis thaliana show confirmed reactivity with Spinacia oleracea (spinach) and Chlamydomonas reinhardtii (green algae), as well as predicted reactivity with Cannabis sativa and other higher plants . This cross-reactivity stems from the evolutionary conservation of ATP synthase structure across photosynthetic organisms.
For bacterial systems, antibodies developed against Escherichia coli atpF may have limited cross-reactivity with more distantly related species due to sequence divergence . Researchers should carefully evaluate sequence homology between their target organism and the immunogen used to generate the antibody. When cross-reactivity data is unavailable, preliminary validation experiments are essential before proceeding with full-scale studies. This validation should include Western blot analysis with positive and negative controls to confirm specificity and sensitivity across the species of interest.
According to the search results, atpF antibodies have been validated for several experimental applications. Plant-specific atpF antibodies (CF0I subunit) have been validated for Blue Native PAGE (BN-PAGE) and Western blot (WB) applications with recommended dilutions of 1:5000 for both techniques . This indicates their utility in studying protein complexes while maintaining native protein interactions.
For bacterial atpF antibodies, validated applications include ELISA and Western blot . These applications enable researchers to quantify atpF protein levels and examine protein expression patterns, respectively. The antibodies have been particularly tested with samples from Escherichia coli strain ATCC 8739, suggesting their specificity for bacterial ATP synthase research.
Researchers should note that applications beyond those explicitly validated may require optimization and preliminary testing. For instance, while immunoprecipitation is not mentioned as a validated application in the search results, the high specificity of the antibodies suggests they might be suitable for this purpose after appropriate validation.
Optimizing Western blot protocols for atpF detection requires careful consideration of several factors. Based on the information provided, researchers should consider:
Dilution factors: For plant-specific atpF antibodies, a dilution of 1:5000 is recommended for Western blot applications . For bacterial atpF antibodies, optimal dilutions may vary and should be determined empirically.
Sample preparation: Since atpF is a membrane-associated protein component of ATP synthase, effective membrane protein extraction protocols are crucial. Gentle detergents that maintain protein structure while ensuring solubilization should be selected based on the experimental organism.
Buffer systems: Considering the preservative (0.03% Proclin 300) and storage buffer (50% Glycerol, 0.01M PBS, pH 7.4) used for some atpF antibodies , compatible buffer systems should be employed throughout the Western blot procedure to maintain antibody activity.
Expected molecular weight: Researchers should be aware that the expected molecular weight for plant atpF (CF0I subunit) is approximately 21 kDa . Bacterial atpF may differ in size, necessitating reference to protein databases for the specific experimental organism.
Controls: Positive controls using recombinant atpF protein or samples known to express atpF should be included, alongside negative controls lacking the target protein.
For studying atpF in its native protein complexes, Blue Native PAGE (BN-PAGE) is specifically recommended in the search results . This technique preserves protein-protein interactions and is particularly valuable for studying membrane protein complexes like ATP synthase. When implementing BN-PAGE for atpF analysis:
Sample preparation should employ gentle detergents that maintain the integrity of protein complexes while ensuring solubilization from membranes.
Coomassie Blue G-250 dye provides the negative charges necessary for electrophoretic separation without denaturing protein complexes.
The recommended antibody dilution of 1:5000 should be used for immunodetection following BN-PAGE separation .
Subsequent second-dimension SDS-PAGE can provide insights into the subunit composition of complexes containing atpF.
Additionally, co-immunoprecipitation could be employed to identify interaction partners of atpF, though this would require validation of the antibody's suitability for immunoprecipitation applications. For advanced analysis, cross-linking mass spectrometry could reveal detailed structural information about atpF's position and interactions within the ATP synthase complex.
AtpF antibodies serve as valuable tools in bioenergetics research by enabling the study of ATP synthase assembly, regulation, and function across different organisms and conditions. In chloroplast research, atpF antibodies allow investigation of how environmental factors affect photosynthetic ATP production by monitoring changes in CF0I subunit levels or modifications . In bacterial systems, these antibodies can be used to study energy metabolism adaptations under various growth conditions .
Advanced applications include:
Using atpF antibodies to track ATP synthase assembly intermediates, providing insights into the biogenesis of this crucial enzyme complex.
Combining atpF immunodetection with functional assays of ATP synthesis to correlate protein levels with enzymatic activity.
Employing atpF antibodies in high-throughput screening approaches to identify compounds that specifically target ATP synthase, potentially leading to new antibiotics or herbicides.
Utilizing atpF detection in comparative studies across species to understand evolutionary adaptations in energy metabolism.
These applications contribute to fundamental understanding of bioenergetic processes and have implications for fields ranging from agriculture to medicine.
Although immunofluorescence is not explicitly mentioned as a validated application for atpF antibodies in the search results, researchers may adapt these antibodies for localization studies. When doing so, several important considerations should be addressed:
Fixation methods: Since atpF is a membrane-associated protein, fixation protocols should preserve membrane structures while allowing antibody access. Paraformaldehyde fixation followed by membrane permeabilization is typically suitable.
Background reduction: Chloroplast and bacterial membranes can exhibit autofluorescence, potentially interfering with specific signal detection. Appropriate controls and background subtraction methods should be implemented.
Co-localization studies: Combining atpF antibody staining with markers for specific subcellular compartments (thylakoid membranes in plants or cell membranes in bacteria) can provide valuable spatial information about ATP synthase distribution.
Resolution limitations: Standard fluorescence microscopy may not resolve individual ATP synthase complexes. Super-resolution techniques may be necessary for detailed localization studies.
Validation of specificity: Knockout or knockdown controls should be included to confirm antibody specificity in immunofluorescence applications.
When researchers encounter contradictory results using atpF antibodies, systematic troubleshooting and analysis are essential. Common sources of contradictions and their resolution approaches include:
Robust experimental design incorporating appropriate controls is crucial for reliable atpF antibody-based research. Essential controls include:
Positive controls: Samples known to contain the target atpF protein, such as purified recombinant protein or extracts from organisms known to express atpF abundantly. This confirms antibody functionality.
Negative controls: Samples lacking the target, such as knockout mutants or tissues not expressing atpF. For plant studies, non-photosynthetic tissues may serve as negative controls for chloroplast atpF .
Loading controls: Detection of housekeeping proteins or total protein staining to normalize atpF signals across samples, especially important for quantitative comparisons.
Antibody specificity controls: Pre-adsorption of the antibody with purified antigen to confirm signal specificity, or use of secondary antibody-only controls to identify non-specific binding.
Cross-reactivity controls: When working with new species, comparative analysis with well-characterized systems helps validate antibody performance.
Technical replicates: Multiple independent experiments to ensure reproducibility and distinguish biological variations from technical artifacts.
Implementation of these controls enables confident interpretation of results and facilitates troubleshooting when unexpected observations arise.
Accurate quantification of atpF levels requires attention to several methodological aspects:
Standardization of protein extraction: Consistent extraction protocols are essential, particularly for membrane proteins like atpF, to ensure comparable recovery across samples. Detergent selection and concentration should be optimized for the specific experimental system.
Quantitative Western blotting: For relative quantification, researchers should ensure signal linearity by testing multiple sample dilutions and exposure times. Digital imaging and analysis software should be used for densitometry rather than film-based detection.
ELISA-based quantification: For absolute quantification, standard curves using purified recombinant atpF protein should be generated. The atpF antibody has been validated for ELISA applications in certain systems .
Mass spectrometry-based approaches: For high-precision quantification, selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) mass spectrometry using isotope-labeled standards provides absolute quantification independent of antibody affinity variations.
Normalization strategies: Quantification should include normalization to appropriate references, such as total protein content, housekeeping proteins, or cell number, depending on the experimental question.
Statistical analysis: Appropriate statistical tests should be applied to determine the significance of observed differences, considering biological and technical variability.
Several factors can influence antibody recognition of atpF, potentially affecting experimental outcomes:
Post-translational modifications (PTMs): Phosphorylation, acetylation, or other PTMs may alter epitope recognition by antibodies. If the antibody's epitope contains potential modification sites, detection efficiency may vary depending on the protein's modification state.
Protein conformation: Native versus denatured conditions significantly impact epitope accessibility. The recommended use of atpF antibodies in both Western blot (denaturing) and Blue Native PAGE (native) applications suggests epitope resistance to denaturation , but this may vary between different antibody products.
Protein-protein interactions: In assembled ATP synthase complexes, some atpF epitopes may be masked by interactions with other subunits. This is particularly relevant for immunoprecipitation or immunofluorescence applications.
Sample preparation conditions: pH, salt concentration, and detergent choice can affect protein conformation and antibody binding. Optimization of these parameters is essential for consistent results.
Cross-reactive proteins: In some experimental systems, proteins with structural similarity to atpF may cross-react with the antibody. Thorough validation is necessary when working with understudied organisms.
Antibody storage and handling: Repeated freeze-thaw cycles can degrade antibody performance. Following manufacturer recommendations for storage at -20°C or -80°C and avoiding repeated freezing and thawing is crucial for maintaining reactivity .
When designing comparative studies of atpF across different species, researchers should consider several key factors:
When applying atpF antibodies to novel experimental systems not previously characterized, researchers should implement a systematic validation approach:
Initial characterization: Begin with bioinformatic analysis to identify atpF homologs in the novel system and assess sequence similarity to the immunogen used to generate available antibodies.
Step-wise validation: Start with Western blot analysis to confirm antibody recognition of a protein with the expected molecular weight. The expected molecular weight of plant CF0I subunit is approximately 21 kDa , while bacterial atpF may differ.
Specificity confirmation: Employ genetic approaches (RNAi, CRISPR-Cas9) to reduce atpF expression and confirm corresponding reduction in antibody signal. Alternatively, heterologous expression of the target organism's atpF in a well-characterized system can confirm antibody recognition.
Application expansion: Once basic reactivity is established, gradually expand to more complex applications such as immunohistochemistry or co-immunoprecipitation, validating each new application independently.
Optimization of experimental conditions: Systematically test variables including fixation methods, buffer compositions, antibody concentrations, and incubation conditions to determine optimal parameters for the novel system.
Development of system-specific controls: Establish positive and negative controls specific to the novel experimental system to facilitate interpretation of results in future studies.
AtpF antibodies offer valuable tools for evolutionary studies of ATP synthase structure and function across diverse organisms:
Comparative expression analysis: Using validated atpF antibodies, researchers can compare expression levels and patterns across evolutionary lineages, providing insights into how energy production mechanisms have adapted to different ecological niches.
Structural conservation assessment: The reactivity of atpF antibodies across species can indicate structural conservation of key epitopes. For example, the plant atpF antibody shows confirmed reactivity with Arabidopsis thaliana, Chlamydomonas reinhardtii, and Spinacia oleracea , suggesting conservation of structure despite evolutionary divergence.
Functional adaptation studies: Combining atpF detection with functional assays of ATP synthase enables correlation between structural variations and functional adaptations across species, illuminating the relationship between protein sequence, structure, and function in evolutionary context.
Environmental adaptation research: AtpF antibodies can facilitate studies of how ATP synthase composition and abundance respond to environmental pressures across species, providing insights into evolutionary adaptations to different energy availability scenarios.
Horizontal gene transfer investigation: In bacterial systems, atpF antibodies could help trace potential horizontal gene transfer events by identifying unexpected structural similarities in ATP synthase components across distant bacterial lineages.
Endosymbiosis research: In eukaryotes, comparing chloroplast, mitochondrial, and bacterial ATP synthase components using specific antibodies can provide insights into the evolutionary history of these organelles and their bacterial ancestors.